Contact Chris

Speaking Engagements

  

In 2023, there will be significant interest in glial cell models, neuroinflammatory biomarkers, and optimizing approaches to target LRKK2, TREM2, and other neurological indications. As a result, large biopharmaceutical companies are expanding their departments in these areas. The 5th Annual Neuroimmunology Drug Development meeting will bring togeth

25-27 April 2023
  

Join us at the Fluid & Imaging Biomarkers in Neuroscience Summit, the premier industry forum bringing together translational experts, neuroscience drug sponsors, and biomarker technology developers. This groundbreaking event aims to revolutionize the assessment of Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyo

22-24 August 2023